American Academy of Family Physicians

Printer-friendly version

Share this on AAFP Connection

Share this page

More Children's Medications From Shuttered McNeil Plant Recalled

Blacksmith Brands Pulling Four PediaCare Products From Market as Precaution

By News Staff

Problems at McNeil Consumer Healthcare's Fort Washington, Pa., facility have led to another recall of children's medications.
PediaCare Decongestant label
Blacksmith Brands Inc. announced May 28 that it is voluntarily recalling all lots of four products in its PediaCare line. The company said in a news release that it is recalling the OTC products as a precautionary measure because they were manufactured for Blacksmith by McNeil Consumer Healthcare at McNeil's Fort Washington plant.

McNeil closed that facility after the FDA issued a highly critical report (17-page PDF; About PDFs) on April 30 that said the plant did not meet the agency's good manufacturing practices requirements.

That same day, McNeil announced it was recalling all unexpired lots of certain brand-name OTC children's and infants' liquid medications -- including more than 40 variations of Tylenol, Motrin, Zyrtec and Benadryl products -- because of manufacturing deficiencies at the Fort Washington facility.

Blacksmith said in its release that it had not received any consumer complaints or reports of adverse events associated with the PediaCare products. However, the company said that although the potential for serious adverse events is remote, consumers who have purchased the recalled PediaCare products are advised to discontinue their use.

The four PediaCare items involved in the recall are
  • PediaCare Multi-Symptom Cold,
  • PediaCare Long-Acting Cough,
  • PediaCare Decongestant and
  • PediaCare Allergy & Cold.
PediaCare Allergy, PediaCare Gentle Vapors Vapor-Plug Unit & Nightlight, and PediaCare Gentle Vapors refills were not produced at McNeil's Fort Washington facility and are not included in the recall, Blacksmith said.

Blacksmith said it plans to shift production of the recalled products to other manufacturing plants and expects to resume shipping in July.

Consumers with questions about the recalled products may contact Blacksmith at (888) 474-3099. Adverse events associated with the use of these products should be reported to the FDA's MedWatch Program.

Share this on AAFP Connection

Health of the Public

Study: PPI Does Not Routinely Improve Asthma Control

Recalled Oral Contraceptives Pose Pregnancy Risk

CDC to Fund 2D Vaccine Barcoding Pilot

2012 Immunization Schedules Reflect Multiple Changes

Study: Cognitive Decline Detected in Middle-aged Adults

CDC Toolkit Can Help Clinicians Fight Norovirus Infection

Patient-Centered Care Linked to Lower Mortality

Study: Inappropriate Cancer Screenings Continue

Novartis Manufacturing Plant Closes After Drug Mix-ups

FDA Announces Classwide REMS for TIRF Medications

New Infants' Acetaminophen Products Hit Store Shelves

Avoid Environmental Factors Linked to Breast Cancer

Risk for Thrombosis Prompts REMS for Rivaroxaban

Common Drugs Implicated in Most Emergency Hospitalizations

CDC Launches Campaign for Child Medication Safety

HHS Blocks Expanded OTC Access to Plan B

Push Is On to Vaccinate Pregnant, Postpartum Women

FDA Committee Votes to Broaden PCV13 Indication

AAFP Foundation Program Aims to Fight Chronic Disease

NIAAA Alcohol Screening Guide Targets Teens

Walgreens, AAFP Launch Flu Vaccine Pilot in Five States

Helping Patients Quit Smoking Starts With a Question

Trilipix Efficacy in Question, Says FDA

USPSTF Addresses Skin Cancer, Obesity, Cervical Cancer Screening

AAFP Endorses ACP Guideline on ED

ACIP Recommends Expanded HPV, Hepatitis B Vaccination

Bacterial Contamination Spurs Nasal Spray Recall

CDC Renews Call for PCV13 Vaccination

USPSTF Recommends Against PSA Screening

AAFP Supports HHS' Million Hearts Initiative

FDA Phases Out Primatene Mist Inhalers

AHRQ Guides Explain Benefits, Risks of GERD Treatments

Tar Wars Winner Gives Back

Office Champions Project Nets Smoking Cessation Gains

Multiple Lots of Oral Contraceptives Recalled

New Vaccine Review Finds Few Adverse Events

HPV Vaccination Rates Still Lag, Says CDC

Renal Injury Prompts Reclast Label Changes

High-dose Citalopram Linked to Abnormal Heart Rhythms

AHRQ Sleep Apnea Guides Review Diagnosis, Management

Board Chair Spotlights Breadth of Family Medicine Training

USPSTF Softens Stance on Bladder Cancer Screening

HHS Expands Coverage for Women's Preventive Services

Teledermatology Project Aids Underserved Patients

New Chantix Warnings Cite Cardiovascular Risk

Pertussis Outbreaks Lead to CDC Alert on PCR Testing